Stella, C. L., Sibai, B. M.: Preeclampsia: Diagnosis and management of the atypical presentation. J. Matern. Fetal. Neonatal. Med., 2006, 19 , 381
Ghulmiyyah, L., Sibai, B.: Maternal mortality from preeclampsia/eclampsia. Semin. Perinatol., 2012, 36 (1), 56–59. Folkman, J., Merler, E., Abernathy, C., et al.: Isolation
Sibai, B., Dekker, G., Kupferminc, M.: Pre-eclampsia. Lancet, 2005, 365 , 785–799. Kupferminc M. Pre-eclampsia
mtsai: Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis. J. Obstet. Gynaecol. Can., 2009, 31 , 818
Cudihy, D., Lee, R. V.: The pathophysiology of pre-eclampsia: current clinical concepts. J. Obstet. Gynaecol., 2009, 29 , 576–582. Lee R. V
Witlin, A. G., Sibai, B. M.: Hypertension in pregnancy: current concepts of preeclampsia. Annu. Rev. Med., 1997, 48 , 115–127. Sibai B. M
Introduction Preeclampsia is a severe complication of pregnancy and a possible cause of maternal morbidity and mortality. It is a multisystem hypertensive disorder with a wide clinical spectrum that includes severe preeclampsia, eclampsia, hemolysis
Introduction Preeclampsia is a severe complication of pregnancy and a possible cause of maternal morbidity and mortality. It is a multisystem hypertensive disorder with a wide clinical spectrum that includes severe preeclampsia, eclampsia, hemolysis
M.K. McLaughlin 1989 Preeclampsia: an endothelial cell disorder Am J Obstet Gynecol 161 5 1200 1204
Introduction Pre-eclampsia, characterized by hypertension and proteinuria occurring after mid-gestation, is a severe complication of human pregnancy with worldwide reported incidence of between 2% and 8% [ 1 , 2 ]. It is
